Literature DB >> 6304514

Molecular heterogeneity of inherited antithrombin III deficiency.

E V Prochownik, S Antonarakis, K A Bauer, R D Rosenberg, E R Fearon, S H Orkin.   

Abstract

Inherited antithrombin III deficiency is associated with an increased risk of thromboembolism. Using recombinant-DNA techniques, we isolated a molecular probe for the antithrombin III structural gene and identified a common DNA polymorphism within the gene. We found that there is genetic heterogeneity in this disorder. In one family, the antithrombin III gene was deleted in affected members, whereas in another no deletion occurred. Use of the DNA polymorphism should allow identification and further characterization of abnormal antithrombin III genes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304514     DOI: 10.1056/NEJM198306303082601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  22 in total

1.  Pleiotropic effects of antithrombin strand 1C substitution mutations.

Authors:  D A Lane; R J Olds; J Conard; M Boisclair; S C Bock; M Hultin; U Abildgaard; H Ireland; E Thompson; G Sas
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  DdeI polymorphism in intron 5 of the ATIII gene.

Authors:  M E Daly; D J Perry
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

3.  Analysis of three restriction fragment length polymorphisms in the human type II procollagen gene.

Authors:  C E Eng; C M Strom
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

4.  Polymorphisms in factor V and antithrombin III gene in recurrent pregnancy loss: a case-control study in Indian population.

Authors:  Amit Sharma; Teena Bhakuni; Ravi Ranjan; Ravi Kumar; Kamal Kishor; Vineet Kumar Kamal; Manoranjan Mahapatra; Mohamad Aman Jairajpuri; Renu Saxena
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

5.  Chromosome 13 homozygosity in osteosarcoma without retinoblastoma.

Authors:  T P Dryja; J M Rapaport; J Epstein; A M Goorin; R Weichselbaum; A Koufos; W K Cavenee
Journal:  Am J Hum Genet       Date:  1986-01       Impact factor: 11.025

6.  Associated von Willebrand disease as a possible cause of lack of thrombosis in an AT III abnormality (AT III Trento).

Authors:  A Girolami; M G Cappellato; M A Vicarioto; S Casonato; F Marafioti
Journal:  Blut       Date:  1986-01

7.  Evidence linking familial thrombosis with a defective antithrombin III gene in two British kindreds.

Authors:  S H Sacks; J M Old; S T Reeders; D J Weatherall; A S Douglas; J H Winter; C R Rizza
Journal:  J Med Genet       Date:  1988-01       Impact factor: 6.318

8.  DNA polymorphism and clinical genetics.

Authors:  R Chakraborty
Journal:  Indian J Pediatr       Date:  1986 Nov-Dec       Impact factor: 1.967

9.  Effect of danazol on the biochemical abnormality of inherited antithrombin III deficiency.

Authors:  A J Fairfax; R M Ibbotson
Journal:  Thorax       Date:  1985-09       Impact factor: 9.139

10.  Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon.

Authors:  T Ariga; T Igarashi; N Ramesh; R Parad; M Cicardi; A E Davis
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.